SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-20-141007
Filing Date
2020-12-31
Accepted
2020-12-31 16:40:47
Documents
4
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2039670-1_pre14a.htm PRE 14A 198042
2 GRAPHIC lg_onconovanew-4clr.jpg GRAPHIC 36715
3 GRAPHIC tm2039670d1_pc1.jpg GRAPHIC 557462
4 GRAPHIC tm2039670d1_pc2.jpg GRAPHIC 258260
  Complete submission text file 0001104659-20-141007.txt   1360907
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36020 | Film No.: 201429237
SIC: 2834 Pharmaceutical Preparations